140 related articles for article (PubMed ID: 38741494)
1. [Anti-Myelin-associated Glycoprotein Neuropathy].
Kuwahara M
Brain Nerve; 2024 May; 76(5):540-546. PubMed ID: 38741494
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2012 May; (5):CD002827. PubMed ID: 22592686
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Expression of Nodal and Paranodal Molecules in Neuropathy Associated With IgM Monoclonal Gammopathy With Anti-Myelin-Associated Glycoprotein Antibodies.
Kawagashira Y; Koike H; Takahashi M; Ohyama K; Iijima M; Katsuno M; Niwa JI; Doyu M; Sobue G
J Neuropathol Exp Neurol; 2020 Dec; 79(12):1303-1312. PubMed ID: 32856086
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2006 Apr; (2):CD002827. PubMed ID: 16625561
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2003; (1):CD002827. PubMed ID: 12535440
[TBL] [Abstract][Full Text] [Related]
7. Anti-myelin-associated glycoprotein neuropathy.
Steck AJ; Stalder AK; Renaud S
Curr Opin Neurol; 2006 Oct; 19(5):458-63. PubMed ID: 16969155
[TBL] [Abstract][Full Text] [Related]
8. [Neuropathies associated with monoclonal IgM anti-MAG antibodies].
Pihan M; Decaux O; Marcorelles P; Bahon-Riedinger I; Lemercier S; Gainche-Salmon A; Doncker AV
Rev Med Interne; 2012 Dec; 33(12):686-92. PubMed ID: 22726239
[TBL] [Abstract][Full Text] [Related]
9. Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets.
Castellani F; Visentin A; Schirinzi E; Salvalaggio A; Cacciavillani M; Candiotto C; Baratè C; Cellini A; Bertorelle R; Siciliano G; Trentin L; Briani C
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37137530
[TBL] [Abstract][Full Text] [Related]
10. [Beneficial effects of rituximab in a case of anti-myelin antibody-associated neuropathy].
Shimoyama T; Yaguchi H; Sengoku R; Matsuno H; Mitsumura H; Kono Y; Mochio S
Rinsho Shinkeigaku; 2011 May; 51(5):345-9. PubMed ID: 21706832
[TBL] [Abstract][Full Text] [Related]
11. Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.
El-Difrawy MM; Zaki NE; Marouf HM; Ayad MW; Farag AM
Int J Hematol; 2012 Jan; 95(1):71-6. PubMed ID: 22193843
[TBL] [Abstract][Full Text] [Related]
12. Anti-myelin-associated glycoprotein neuropathy: Where do we stand?
Stino AM; Elsheikh B; Allen JA
Muscle Nerve; 2023 Nov; 68(6):823-832. PubMed ID: 37602932
[TBL] [Abstract][Full Text] [Related]
13. [Neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein (MAG) antibody].
Kawagashira Y; Koike H; Sobue G
Nihon Rinsho; 2015 Sep; 73 Suppl 7():440-5. PubMed ID: 26480739
[No Abstract] [Full Text] [Related]
14. Pupil-involving third nerve palsy as a manifestation of anti-myelin-associated glycoprotein neuropathy.
Tamhankar MA; Galetta SL; Massaro M; Balcer LJ; Stadtmauer EA; Brown MJ
J Neuroophthalmol; 2011 Mar; 31(1):29-33. PubMed ID: 21164358
[TBL] [Abstract][Full Text] [Related]
15. [Anti-myelin-associated glycoprotein antibody positive IgM monoclonal gammopathy related peripheral neuropathy: 11 cases and literature review].
Gao XM; Jia MN; Qian M; Ren HT; Zhang L; Shen KN; Cao XX; Li J
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):901-905. PubMed ID: 31856437
[No Abstract] [Full Text] [Related]
16. [Rapid improvement by rituximab treatment in a case of demyelinating polyneuropathy with anti-myelin-associated glycoprotein antibody].
Motoyama R; Yamakawa K; Suzuki S; Kusunoki S; Tanaka M
Rinsho Shinkeigaku; 2011 Oct; 51(10):761-4. PubMed ID: 22019868
[TBL] [Abstract][Full Text] [Related]
17. Are electrophysiological features related to disability in patients with anti-MAG neuropathy?
Gesquière-Dando A; Delmont E; Launay M; Boucraut J; Attarian S
Neurophysiol Clin; 2017 Feb; 47(1):75-81. PubMed ID: 28161089
[TBL] [Abstract][Full Text] [Related]
18. Anti-MAG associated cerebellar ataxia and response to rituximab.
Zis P; Rao DG; Hoggard N; Sarrigiannis PG; Hadjivassiliou M
J Neurol; 2018 Jan; 265(1):115-118. PubMed ID: 29159464
[TBL] [Abstract][Full Text] [Related]
19. [Polyneuropathy involving cranial nerves associated with monoclonal IgM antibodies with anti-MAG/SGPG/SGPLG/sulfatides activity].
Drouet A; Caudie C; Vallat JM; Ruel JH; Felten D; Guilloton L; Giraud P
Rev Neurol (Paris); 2006 Jun; 162(6-7):760-6. PubMed ID: 16840988
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of the
Vos JM; Notermans NC; D'Sa S; Lunn MP; van der Pol WL; Kraan W; Reilly MM; Chalker J; Gupta R; Kersten MJ; Pals ST; Minnema MC
J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):1007-1009. PubMed ID: 29018161
[No Abstract] [Full Text] [Related]
[Next] [New Search]